Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study
By E. Grube, J. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann and 2 more. Circulation, 2006
719 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/4b994209ffb09f2922d8f34b506258a99dd0ec6a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Zahn
- U. Gerckens
- A. Linke
- H. Sievert
- G. Richardt
- H. Eggebrecht
- E. Grube
- R. Hambrecht
Citations in the corpus
- Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. (2011, background): “First single-centre case series have demonstrated the feasibility and efficacy of the balloon-expandable Sapien Edwards prosthesis (Edwards Lifesciences LLC, Irvine, CA, USA)(8) as well as the selfexpandable CoreValve, now Medtronic CoreValve (Medtronic CoreValve, Irvine, CA, USA), prosthesis.(9) –1”